Zoe has extensive experience in marketing, corporate and investor communications in the science and healthcare sector. Zoe joined Oxford Nanopore in January 2008, bringing expertise in pre-marketing of products, building and management of corporate reputation, IR and fundraising. At Oxford Nanopore Zoe works with the executive and management teams to ensure that the business development plan is supported by strategic serving of investor, customer and other stakeholder relationships. She also works on the fundraisings that have so far raised £74 million.
Zoe gained a BSc in Physiology, specialising in electrophysiology and neurophysiology, at the University of Bristol. The first years of her career were spent with SmithKline Beecham, working in sales and marketing. Zoe then joined Porter Novelli, where she consulted on marketing communications and issues management for companies including Glaxo Wellcome, Novartis and Bristol-Myers Squibb and conducted award-winning work on the blood products/ nvCJD issue for BPL, part of the National Blood Service.
At specialty pharmaceutical company Sinclair Pharmaceuticals, Zoe played an integral role in the £60m IPO and headed subsequent corporate and investor communications. In 2005, Zoe worked with a Sri Lankan humanitarian organization to create and manage a mobile medical unit, serving populations displaced by the Asian tsunami and civil unrest